Liver disease is one of the major health problems in many countries. Mesenchymal Stem cells have opened a new approach to deal with liver fibrosis. Improvement of bone marrow derived mesenchymal stem cellshoming after systemic injection of disintegrin/like domain purified from Egyptian horned Cerastes cerastes crude venomwhichwas shown byprevious study. This work was designed to investigate the possible mechanism of disintegrin/like domainin mesenchymal stem cells homing to fibrotic liver of CCl 4 treated mice. Quantitative gene expression was performed for stromal cell-derived factor-1α to study homing of bone marrow derived mesenchymal stem cells, transforming growth factor beta 1 to study bone marrow derived mesenchymal stem cellshoming and regeneration of liver cells and hepatocyte growth factor to study regeneration of liver cells in CCl 4 induced liver injury in white albino mice. It was found that disintegrin/like domaincould increase homing ofbone marrow derived mesenchymal stem cells as showed by the significant increase in liver stromal cell-derived factor -1α gene expression, transforming growth factor beta 1 as well as hepatocyte growth factor genes expression compared to the non disintegrin/like domaintreated CCl 4 group.
INTRODUCTION
Mesenchymal stromal cells (MSCs) are non-haematopoietic cells that were first obtained from the bone marrow (Friedenstein et al., 1974) .There is great interest in using these cells in therapy ofwide variety of clinical problems (Wang et al., 2015 and De Becker A, Van Riet,2015) .Mesenchymal stromal cells have immunomodulatory effect, multipotentcapacity and tend to migrate to sites of tissue injury (Chapel et al., 2003 andNasef et al., 2009 ). In addition, MSCs can suppress inflammatory responses, reduce hepatocyte apoptosis, increase hepatocyte regeneration, and rescue liver fibrosis (Eom et al., 2015) .Homing isa major problem in the field of cell-based therapy which means the ability of cells to migrate into the site of injury. Homing is a multistep process that includes cell attachment and rolling in the vessel lumen, adhesion and extravasation across the vascular endothelium and migration through the tissue stroma (Kholodenko et al., 2013) . Many potential factors are involved in stem cells migration and homing into the injured liver have been characterized, such as stromal cell-derived factor-1α (SDF-1α/CXCR4) axis, lytic enzymes as matrix metalloproteinase (MMPs), hypoxia induced factor -1(HIF-1), hepatocyte growth factor (HGF),inflammatory cytokines such as (transforming growth factor beta 1(TGF-β1), interleukin-1β (IL-1β) and tumor necrosis factor-α(TNF-α) (Sohni and Verfaillie, 2013) . Disintegrins are small cysteine-rich non-enzymatic proteins that are created by the proteolysis of larger precursor of snake venom metalloproteinase (Takeda et al., 2012) . They have been found to inhibit platelet aggregation, angiogenesis, metastasis and tumor growth (Amiryan, 2011) . The value of disintegrin/like domainobtained from Egyptian horned Cerastes cerastes crude venom as hepatoprotective (Zaki et al., 2011) and potential stimulator of mesenchymal stem cells homing was reportedin albino mice(Abd EL-Wahab et al., 2014). Stromal cell-derived factor-1α is constitutively expressed in healthy liver. Its expression increases following acute or chronic liver
injury.Stromal cell-derived factor-1α (SDF-1α)is able to activate two chemokine receptors with various downstream signaling pathways,C -X -C chemokine receptor type 4 (CXCR4) and C -X -C chemokine receptor type 7 (CXCR7).C -X -C chemokine receptor type7 is much more expressed inliver sinusoidal endothelial cells (LSEC), while hepatic stellate cells (HSC), mesenchymal stem cells, and tumor cells mainly respond by CXCR4 expression(Liepelt and Tacke, 2016).
Hepatocyte growth factorhas pleiotropic effects on liver cells, influencing cell proliferation, apoptosis, differentiation, motility, invasion and angiogenesis (Weiskirchen, 2015) . The positive role of HGF in facilitating the differentiation of stem cells has been recognized as a rational approach to improve the efficacy of MSC transplantation (Hahn et al., 2008) . Transforming growth factor beta 1is a multifunctional cytokine (Thenappan et al., 2011) .Transforming growth factor beta 1is hypothesized to serve as the vital link among liver regeneration, chronic injury, cirrhosis, and hepatocellular carcinoma (Thenappan et al.,2010) .It is hypothesized that TGF-β1 may mediate SDF-1α/CXCR4 axis-induced MSCs homing (Si et al., 2015) . This study investigated the possible mechanism by which disintegrin /like domain could enhance the homing of labeled bone marrow mesenchymal stem cells to CCl 4 induced liver injury model in white albino mice. 
MATERIALS AND METHODS

Purification and isolation of disintegrin
Experimental design:
Male white albino mice of average weight (25-30 g/mouse)were kept in wire cages at animal house under standard conditions. Food and water were available ad-libitum (fed freely with the quantity and frequency of consumption of choice of animals). They were divided randomly into 5groups, each of 8 animals(Abd EL-Wahab et al.,
Amal Said Darwish et all ‫ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ‬ ‫ـــــــــــــــــ‬ ‫ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ‬ ‫ـــــــــ‬ 116 2014): Group 1 (control): Injected intra-peritoneally (i.p.) with normal saline once weekly for 3 weeks in a dose of 0.8 ml/kg body weight then sacrificed one week later; Group 2: Injected (i.p.)with CCl 4 0.8 ml (95%)/kg body weight once weekly for 3 successive weeksthen sacrificed one week later; Group 3: Injected (i.p.)with CCl 4 0.8 ml (95%)/kg once weekly for 3 successive weeks followed one week later by (i.p.)injection of disintegrin/likedomain 0.3 mg/kg once weekly for 2 successive weeks then sacrificed one week later; Group 4: Injected (i.p.)with CCl 4 0.8 ml/kg once weekly for 3 successive weeks followed one week later by intra-venous injection of 0.5 ml labeled BM-MSCs(2 ×10 6 cells/ml once) (cells were injected intra-venous into mice tail vein)then sacrificed3 weeks later; Group 5: Injected (i.p.)with CCl 4 0.8 ml (95%)/kg once weekly for 3 successive weeks followed one week later by intra-venous injection of0.5 ml labeled BM-MSCs(2 ×10 6 cells/ml)(cells were injected intra-venous into mice tail vein) and (i.p.)injection of disintegrin/like domain 0.3 mg/kg then sacrificed 3 week later.This work was approved by research ethics committee, faculty of medicine-Ain shams university (NO. FWA 000017585). All groupswere anaesthetized by ether and blood samples were obtainedby periorbital route (Joanna et al., 2015) andsacrificed to obtain the liver tissues.Hepatic specimens were treated for Real Time PCR and histo-pathological studies.
Biochemical assays:
Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and albumin levels were measured with a biochemical analyzer (Roche Integra 800, Holliston, United States) (Bergmeyer et al., 1985) .
RNA isolation and quantitative real-time RT-PCR:
RNA extraction from liver tissue samples was performed (Otto et al., 1998 
RESULTS
PKH26 fluorescent dyelabeledMSCs were observed in the liver tissues obtained from the group injected with MSCs after CCl 4 (group 4) (figure 1) and the group injected with MSCs and disintegrin/ like domain after CCl 4 (group5) (figure 2)
Serum ALT and AST levels (U/L) were significantly increased in CCl 4 treated animals as compared to that in the control group (P ≤0.01). Serum albumin levels (g/dl) were significantly decreased in animals injected with CCl 4 as compared to the control group (p≤0.01) indicating presence of liver damage (table 2). SerumALT and AST levels were significantly lower in mice injected with disintegrin/ like domain or labeled BM-MSCs or both after CCl 4 injection, compared to that injected with CCl 4 alone (p≤0.01). 
